Or, at the other end of the spectrum, will the statute and accompanying regulations instead cast undue suspicion on relationships that are sometimes ambiguous, often symbiotic, and, in the case of medical research and study, actually beneficial to the public at large?
This has several important implications, which include the increased costs resulting from this third-party interference and the ambiguous nature of trust protector status and duties in American case law.